Nanoparticle Vaccine Elicits Huge Immune Response Against SARS-CoV-2

“The entire S protein has been used as the major antigen in vaccines against this ongoing pandemic,” said Dr. Baozhong Wang, senior author of the study and Distinguished University Professor in the Institute for Biomedical Sciences at Georgia State University.

“However, as the number of infections continues to rise, more and more variants have appeared and supplanted the ancestral virus. For this reason, the efficacy and protection of current vaccines are under constant threat and need continuous improvement.”

“In contrast, the stem is more conserved and has fewer mutations across lineages. In addition, the stem could induce effective antibody neutralization and vigorous antibody-dependent cellular cytotoxicity (ADCC) activity against multiple variants of S protein.

Stabilized stem subunit could be a potential antigen for a SARS-CoV-2 universal vaccine against unpredictable variants.”

Immunization with the stem induced balanced Immunoglobulin G (IgG) antibodies with potent and broad ADCC activity, a type of immune reaction in which infected cells are coated with antibodies that then recruit certain types of white blood cells to kill the infected cells.

The double-layered protein nanoparticles constructed from the stem and the full-length spike protein induced more robust ADCC and neutralizing antibodies than the stem and spike protein, respectively.

Nanoparticles produce more potent and balanced serum IgG antibodies than the corresponding soluble protein mixture, and the immune responses are sustained for at least four months after the immunization.

With a more balanced IgG isotype antibody induced by the stem, long-lasting immune responses, and excellent safety profiles, the double-layered protein nanoparticles have the potential to be developed into broader SARS-CoV-2 vaccines, the study reports.

“The stabilized, conserved S2 stem subunit demonstrated its potential as a universal SARS-CoV-2 vaccine candidate against unpredictable variants,” said Dr. Yao Ma, first author of the study and a postdoctoral research fellow in the Institute for Biomedical Sciences at Georgia State University.

“Our double-layered protein nanoparticles incorporating the full-length spike protein and the S2 stem induced robust and long-term immune responses and exhibited a safety profile in our primary studies, providing an option for current SARS-CoV-2 vaccine development.”

“The pandemic is far from over, and new variants continue to emerge and pose a massive threat to human health. Therefore, the updating of vaccines needs to keep pace with the times to avoid another pandemic with an unpredictable new variant.”

Source: Medindia